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It is known that the presence of fluorophores can influence the dynamics of molecular processes. Despite this, an
affordable technique to control the fluorophore distribution within the sample, as well as the rise of unpredictable
anomalous processes induced by the fluorophore itself, is missing. We coupled a stimulated emission depletion
(STED) microscope with an atomic force microscope to investigate the formation of amyloid aggregates. In par-
ticular, we studied the in vitro aggregation of insulin and two alloforms of b amyloid peptides. We followed stan-
dard methods to induce the aggregation and to label the molecules at different dye-to-protein ratios. Only a
fraction of the fibrillar aggregates was displayed in STED images, indicating that the labeled molecules did not
participate indistinctly to the aggregation process. This finding demonstrates that labeled molecules follow only








Far-field optical microscopy is an essential tool not only in scientific
research but also in clinical analysis and industrial quality control.
The limit of the classical optical observations, fixed byAbbe’s diffrac-
tion limit (1) that imposes a maximum resolution of ~250 nm, is a
severe limitation for analysis at the nanometer scale. In the past two
decades, a series of original approaches open the way to a new class of
far-field microscopy, defined as super-resolution (SR) optical micros-
copy, that shattered the diffraction barrier, improving spatial resolu-
tion by an order of magnitude or more over the diffraction limit. These
techniques providenew insights into biological processes at the, hitherto
inaccessible, molecular scale (2).
SR techniques are fluorescencemicroscopymodes (3–6) based on
the use of fluorescent molecules. Ideal molecular dyes must provide
high specificity, brightness, and stability. While the two latter prop-
erties aremostly related to themolecular structure of the fluorochrome
itself, the specificity depends on the method used to recognize and
bind a particular molecular target (7). Further, the influence of the flu-
orescent dye on the biological processes under investigation should
be minimal.
In particular, covalent fluorescent labeling is commonly applied
in vitro (8). The fluorophores used for covalent labeling are small
molecules (<1 kDa) and are widely used in the study of dynamic pro-
cesses of molecular interaction. Despite this, previous reports high-
lighted that the covalent linkage of fluorophores could affect the
visualization, dynamics, or biological properties of the molecular sys-
tem (9, 10). However, it is not trivial to have a direct and unambiguous
assessment of the efficiency and homogeneity of the labeling, as well as
on the influence that the fluorescent tag has on the molecular activity.
We propose a new approach in the study of misfolded protein
aggregates based on the use of a combined system that couples the
capability of an atomic force microscope (AFM) (11), a primary tech-
nique in the study of amyloid aggregation in vitro (12–14), with that
of a stimulated emission depletion (STED) microscope (15). In par-
ticular, we investigated the aggregation process of a nonpathological
protein, insulin from the bovine pancreas, covalently labeled withN-hydroxysuccinimide (NHS)–dye fluorophore, testing the aggre-
gation at different dye-to-protein ratios (1:19, 1:99, and 1:499). In the
second set of experiments, we used the same approach on widely
used and commercially available fluorescently labeled Ab1–42 and
Ab1–40 (16).
The formation of misfolded protein aggregates is associated with
several pathological conditions (17), such as Alzheimer’s, Parkinson’s,
and Huntington’s diseases, characterized by the conversion of specific
peptides or proteins from their soluble functional states into highly
organized and insoluble fibrillar aggregates. In the past decade, SR
microscopies were applied in the study of the molecular mechanism
associated with misfolded protein diseases.
Direct stochastic optical reconstruction microscopy (dSTORM)
was used to investigate the aggregation of b amyloid (Ab) both in vitro
and in situ.Morphological differences between the species obtained in
vitro and in vivo were detected (18). With two-color dSTORM, the
polarized elongation of Ab1–42 fibrils was also demonstrated (19).
Immunolabeled tau filaments from brain sections were imaged with
a resolution of 77 nm using STEDmicroscopy (20). In a recent study,
the preferential localization of g-secretase in the presynaptic and post-
synaptic compartment has been characterized by STORM and STED
microscopy (21).
In the field of Parkinson’s disease, amyloid fibrils from a-synuclein
were imaged with an unprecedented resolution using binding-activated
localization microscopy (22). Two-color dSTORM was used to study
the elongation of preformed a-synuclein fibrils, providing new insights
into the role of seeding in the fibrillogenesis (23). Last, the fibrillation
of human lysozyme, involved in a fatal form of hereditary systemic
amyloidosis, was characterized in detail (24).
Studying aggregates from both insulin and Ab, we had direct and
incontestable proof of the influence that the molecular dyes have on
the aggregation process. In particular, we demonstrated that a fraction
of labeled peptides follows selected aggregation pathways. The slowing
of the kinetics of aggregation—detectable with several techniques such
as thioflavinT (ThT) binding, Fourier transform infrared spectroscopy,
and time-lapse AFM—is just an aspect of the influence of the labeled
monomers on the intermolecular processes. The results obtained
by correlative AFM-STED microscopy highlight a new and essen-
tial aspect and generate a warning: Fluorescence techniques are not
able to characterize all the products derived from the in vitro aggre-
gation of misfolded proteins. This statement reveals the importance1 of 7
SC I ENCE ADVANCES | R E S EARCH ART I C L Eof correlating fluorescence data with others derived from label-free
techniques. This loss of information that affects not only the imag-
ing but also the spectroscopic techniques based on the fluorescence
of a dye molecule suggests the primary role that can be played by
label-free techniques. This phenomenon is demonstrated here for
three particular peptides (insulin, Ab1–42, and Ab1–40) and uses well-
established and largely diffused labeling methods, but it can likely be
common to other molecular systems and extended to other molec-








Analysis of insulin fibrillar aggregates
ThT fluorescence assay and AFM were used as consolidated tech-
niques to follow the aggregation of insulin and to characterize the
morphology of the fibrils. Insulin fibrils were obtained at three differ-
ent dye-to-protein ratios, called 1:19, 1:99, and 1:499 (see Materials
and Methods). The kinetics of aggregation was slightly delayed by
the presence of a fraction of labeledmonomers (fig. S1).We apply cor-
relative AFM-STEDmicroscopy in the study of mature fibrils, i.e., ag-
gregates after 14 days of incubation in denaturing conditions. Fibrils
have a variable length, and the thickness is slightly affected by the pres-
ence of the dye. In particular, the mean thickness calculated from the
analysis of images acquired in liquid is 6.3 ± 2.7 nm for 1:19 samples,
7.5 ± 2.5 nm for 1:99 samples, and 7.6 ± 2.5 nm for 1:499 samples,
while the thickness of unlabeled insulin fibrils is 5.6 ± 1.7 nm. These
results indicate that the fibril thickness at different dye-to-protein ratios
is compatible within the experimental errors, although the unlabeled
fibrils are slightly thinner, likely due to steric effect or a different orga-
nization of the protofilaments within the fibrillary aggregates.
Considering the tip broadening effects on the AFM images, under
the approximation of cylindrical symmetry, the expected apparent





where R is the radius of curvature of the tip and h is the measured
thickness (25). The reported heights and the nominal R value of the
tip used allow us to conclude that insulin fibrils are notably flattened,Cosentino et al., Sci. Adv. 2019;5 : eaav8062 19 June 2019likely due to the interaction and binding at the glass substrate. In
particular, the mean value of W/W', where W is the measured fibril
width, is 1.7 ± 0.5 in 1:19, 2.6 ± 0.6 in 1:99, 2.0 ± 1.1 in 1:499, and
1.5 ± 0.4 in the absence of labeled peptides.
The fibrillar aggregates at the three different dye-to-protein ratios
were imaged using correlativeAFM-STEDmicroscopy (Fig. 1), follow-
ing the procedure described in Materials and Methods. Images ac-
quired on the 1:19 sample shows a significant presence of unlabeled
fibrils (Fig. 2). The analysis of 10 images derived from three different
preparations indicates a value of correlation of 0.42 ± 0.11 (seeMaterials
and Methods). The same experiment was repeated at 1:99 (Fig. 3, A
to C) and 1:499 (Fig. 3, D to F) samples (three preparations per sample).
So far, the correlation between AFM and STED data drops down at
lower dye-to-protein ratios, and the ratios of colocalization are 0.29 ±
0.07 (1:99, n = 10) and 0.19 ± 0.09 (1:499, n = 10). The single labeled/
unlabeled fibrils are displayed in correlative images on a smaller area
(fig. S2). The pixel-by-pixel correlation is shown in the scatter plots in
fig. S3. All the confocal images acquired on the same area of the STED
images shown here are presented in fig. S4.
Analysis of Ab1–42 and Ab1–40 fibrillar aggregates
The aggregation of Ab1–42 was induced using standard protocol pro-
posed in the literature (26) and described in Materials and Methods.
We characterize the initial state of the aggregation to exclude the
presence of preexistent fibrillar aggregates that could induce impor-
tant artifact in the analysis. AFM images acquired just after the re-
suspension of the lyophilized peptide in the aggregation medium are
shown in fig. S5 and indicate the presence of a monodisperse distribu-
tion of globular aggregates. The dynamic light scattering (DLS)
experiments confirm the data with a mean size of 2.0 ± 0.4 nm. The
absence of fibrillary aggregates at the initial stage of the aggregation
process is confirmed. Ab1–42 aggregates faster than insulin, and after
4 hours of aggregation, fibrillar aggregates, often assembled in clusters,
are present (fig. S6, A to D). ThT assay demonstrated that the kinetics
of aggregation of the labeled peptides is slower (fig. S6, G and H). In
addition, in Ab1–42 samples, the correlative images indicated the pres-
ence of two different types of aggregates (Fig. 4), with a significant
unlabeled fraction of fibrils already present at a dye-to-protein ratio
of 1:19 (Fig. 4, A to C). The correlation between AFM and STED
images, i.e., the population of fibrils that are visible in fluorescenceFig. 1. Correlative imaging. (A) Images of the same area are acquired in different modes. The confocal and STED images are acquired in reflection, while the AFM
probe reaches the sample from above, providing a three-dimensional topographical view at high resolution. (B) Amyloid fibrils from bovine insulin labeled with
fluorescence dye ATTO 488 NHS ester with a 1:19 dye-to-protein ratio. The STED and confocal images are overlaid with AFM topography. The resolution of the STED
microscopy image is significantly enhanced with respect to the confocal microscopy image. At the same time, the AFM provides the topographical image on the same
sample area. Some fibrillar aggregates are not displayed in fluorescence microscopy (e.g., white arrow). Scale bar, 1 mm.2 of 7
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microscopy, decreases at lower dye-to-protein ratios: 0.45 ± 0.13
(1:19), 0.26 ± 0.11 (1:99), and 0.16 ± 0.04 (1:499). The results derived
from two different preparations (15 images per sample).
Further, these results are confirmed onAb1–40 (two preparations at
a 1:19 dye-to-protein ratio), analyzing 22 different images. The pres-
ence of a significant population of unlabeled fibrils is evident in Fig. 4
(J to L). In addition, in this case, we use AFM (fig. S5, E and F) and
DLS techniques to exclude the presence of preformed fibrils at the ini-
tial stage of the aggregation process. The average size of the peptides
just after the resuspension in the aggregation buffer is 2.4 ± 0.3 nm.
Fibrillar aggregates after 1 day of aggregation time are shown in fig. S6.
The scatter plot analysis is shown in fig. S3. All the confocal images
acquired on the same area of the STED images shownhere are presented
in fig. S4.
Characterization of immunolabeled Ab1–42 aggregates
Amyloid fibrils fromAb1–42were labeled via indirect immunolabeling,
following a well-established procedure (see Materials and Methods).
After the conjugation with the fluorescent secondary antibody, we
found that all the fibrillar aggregates displayed by AFM were also vis-
ible in the STED image. As a consequence of this, the correlation be-
tween the AFM and STED images (Fig. 5) is very high for all the
images acquired (n = 12) and for all the preparations (n = 2). The level
of colocalization between AFM and STED images has been quantified
to 0.92 ± 0.05. The typical cross section of the fibrils, measured byCosentino et al., Sci. Adv. 2019;5 : eaav8062 19 June 2019AFM, is significantly increased as a consequence of a massive binding
of antibodymolecules at the fibril surface, with a mean height value of
20.4 ± 7 nm. This indirect proof of the presence of the molecular dyes
is a final example of the potentialities that are opened by the use of a
correlative technique in the study of molecular interaction.DISCUSSION
Amyloid aggregates derived from insulin and two different alloforms
of Ab peptides, Ab1–42 and Ab1–40, were imaged by correlative AFM-
STEDmicroscopy. Our research is mainly focused on mature fibrils.
The aggregation started from solutions of mixed unlabeled and
labeled proteins/peptides at different dye-to-protein ratios (1:19,
1:99, and 1:499). The dye-to-protein ratio of 1:19 was chosen follow-
ing well-established methods previously presented and largely used
(19, 23, 27). We used 1:99 and 1:499 as controls to evaluate how the
presence of fluorescent aggregates rescales with the concentration of
the dye. Insulin was labeled by covalently binding a fluorophore at
the free amine groups, while fluorescent Ab1–42 presented a single
fluorophore at a terminal group and was purchased by an external
company. In both cases, we found that, for all three dye-to-protein
ratios under investigation, fluorescent fibrils coexist with a significant
fraction of aggregates that are mainly or entirely unlabeled.
Insulin from the bovine pancreas is not an amyloidogenic protein
in vivo. On the other hand, it has been demonstrated that peptidesFig. 3. Insulin fibrils at dye-to-protein ratios of 1:99 and 1:499. Insulin fibrils obtained from 1:99 (A to C) and 1:499 (D to F) dye-to-protein ratios. AFM images (A and
D), STED microscopy images (B and E), and correlative images (C and F). Several fibrils are totally unlabeled, while a homogeneous fluorescence is emitted by some
other aggregates. The ratio of colocalization is shown by the histograms (C and F, insets). Scale bars, 2 mm.Fig. 2. Insulin fibrils at a dye-to-protein ratio of 1:19. Insulin fibril (dye-to-protein ratio, 1:19) images with AFM (A), STED microscopy (B), and the correlative images
obtained by (A) and (B) (C). Only a fraction of the fibrillary aggregates is displayed in the optical image. In particular, some fibrils are completely missing, indicating that
the labeled monomers were not taking part in the formation of these aggregates. On the contrary, a continuous distribution of fluorophores is present in other
aggregates. The ratio of colocalization for this particular field of view is indicated by the histogram. Scale bar, 5 mm. Inset (C), overlay graph.3 of 7
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and proteins that are unrelated to disease have a generic ability to
form amyloid fibrils upon destabilization of their native structure in-
duced by particular environmental conditions (28–32). In particular,
we chose insulin because the structure of insulin fibrils, as well as the
number of monomers that are present in a unit length of an insulin
fibril, is well known (33). From small-angle scattering experiments,
considering the radius of gyration and the molecular weight of a fibril
nucleus before the elongation phase, it was calculated that an insulin
fibril with a circular cross section of 6 nm in diameter is formed by
seven protofilaments, and the number of monomer per unit length
was calculated. Comparing thismodelwith themorphological featuresCosentino et al., Sci. Adv. 2019;5 : eaav8062 19 June 2019of our insulin fibrils (average thickness and aspect ratio are reported
in Results) and with the assumption of an indistinct aggregation, in
which fibrils are the result of the stochastic assembly of labeled and
unlabeled monomers, we deduce that at least one labeled molecule
every 6 nm along the fibril axis must be expected in 1:19 samples, one
every 30 nm in 1:99 samples, and one every 150 nm in 1:499 samples.
Thismeans that, considering the resolution achieved in our experimen-
tal conditions, the fibrils must appear entirely fluorescent upon STED
microscopy visualization, at least in the case of 1:19 and 1:99 samples.
The presence of a large population of unlabeled fibrils indicates the
coexistence of distinct aggregation processes; some of them allow theFig. 4. Correlative images of fibrils from Ab. Amyloid aggregates from Ab1–42 (A to I). Different concentrations of fluorescent peptides were present. The dye-to-
protein ratios were 1:19 (A to C), 1:99 (D to F), and 1:499 (G to I). In addition, at the higher dye-to-protein ratio (A to C), some fibrils were not displayed by fluorescence
images (e.g., see the white arrows). For amyloid aggregates from Ab1–40, the dye-to-protein ratio is 1:19 (J to L). Scale bars, 2 mm.4 of 7
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contribution of the labeled peptide in the formation of aggregates,
and the others preclude this contribution (Fig. 6A).
The presence of directly labeled monomers not only slows the ki-
netics of the aggregation (see fig. S1) of insulin but also favors the co-
existence of different aggregation pathways, bringing two distinct final
products: labeled and unlabeled fibrils. We pointed out that the pres-
ence of these two species of aggregates can be evinced only by applying
AFM fluorescence. However, we also noted that super-resolved fluo-
rescence microscopy is unique in providing the sufficient capability of
discerning between different tightly packed filaments arranged in a
confined space.
The same procedure has been applied to the Alzheimer’s disease–
associated peptides Ab1–42 and Ab1–40, demonstrating that the phe-
nomenon described in detail for insulin is general in the process of
aggregation of misfolded proteins. Further, unlabeled aggregates
are also present when the peptides are labeled with a single dye at the
N terminus, a part of the polypeptide chain that has been classically
considered as scarcely relevant in fibrillation processes (19, 27). The
ratio of colocalization obtained as a function of different conditions
is summarized in Fig. 6B. Using a standard indirect immunolabeling
method, we were able to display the entire population of fibrils within
the sample, demonstrating that the loss of information evinced from
directly labeled samples is not related to an instrumental limit but is
inherently related to the sample properties.
These findings define a new and not expected scenario and suggest
the need for new quantitative investigations aimed to characterize the
physicochemical properties of the two species of aggregates, i.e., fluo-
rescent and nonfluorescent aggregates. Further, the analysis should be
extended to the bioactivity of the same species with a particular focus
on their toxicity.Cosentino et al., Sci. Adv. 2019;5 : eaav8062 19 June 2019As awhole, these results indicate that the integration betweenAFM
and SR fluorescence microscopy represents not only a complement
but also a fundamental tool to validate the results deriving from fluo-
rescence microscopy and that it can drive the experiments toward
more accurate and less invasive methods of labeling. AFM-STED
microscopy could be a fundamental test in the validation and inFig. 5. Correlative images from immunolabeled samples. (A to F) Amyloid aggregates formed from Ab1–42 in the absence of fluorescent monomers and subse-
quently labeled via indirect immunolabeling. All the features displayed in the AFM images are also visible in the STED images and are colocalized. The fibril size,
measured by AFM, is larger with respect to the unlabeled fibrils, confirming the presence of a large amount of antibody on the fibrillar aggregates. Scale bars, 2 mm
(A to C) and 1 mm (D to F).Fig. 6. Summary and ratios of colocalization. (A) A stochastic aggregation of
the labeled/unlabeled peptides should bring to the formation of uniformly
labeled fibrils. Our experiments indicate a different scenario where only a fraction
of the fibrils has a labeled component. Other fibrils, dark in the STED analysis, are
unlabeled. These two products are the results of different aggregation pathways.
(B) Table showing the ratio of colocalization calculated for the different peptide
species and dye-to-protein ratios.5 of 7
SC I ENCE ADVANCES | R E S EARCH ART I C L Ethe quality control of the new dyes used for the in vitro study of mo-








Insulin labeling and fibrillation
Bovine insulin was purchased from Sigma-Aldrich (St. Louis, MO,
USA) and used without further purification. The protein was labeled
with fluorescent dyes, ATTO488NHS ester (Sigma-Aldrich, St. Louis,
MO, USA). NHS esters readily react with amino groups of proteins,
i.e., the e-amino groups of lysine or the N terminus, forming a chem-
ically stable amide bond. Labeling was done in a solution of 100 mM
sodium bicarbonate at pH 8.3 and by mixing monomeric insulin at a
final concentration of 2 mg/ml (0.35 mM) with 1 mM ATTO 488,
previously diluted in dimethyl sulfoxide (Thermo Fisher Scientific,
Waltham, MA, USA). After 1 hour under stirring, the proteins were
separated from the excess of free dye via filtration with Amicon Ultra
centrifugal filters (molecular weight cutoff, 3000; Merck Millipore,
Milan, Italy). Immediately after filtration, the concentration of the
labeled proteins was determined spectrophotometrically (Cary spec-
trophotometer, Agilent Technologies, Santa Clara, CA, USA). The
unlabeled insulin monomers were added in HCl (pH 2) solution to
a final dye-to-protein ratio (i.e., labeled:unlabeled insulin) of 1:19,
1:99, and 1:499. The protein concentration was 1 mg/ml. Fibrillation
took place at 60°C in glass vials, without agitation (34). AFMwas used
to verify the fibrillation process in the absence and presence of fluo-
rescent molecules (fig. S1).
Ab1–42 and Ab1–40 fibrillation
Lyophilized synthetic human Ab1–42/Ab1–40 (Bachem, Bubendorf,
Switzerland) was dissolved in 100% hexafluoroisopropanol solu-
tion (1 mg/ml), aliquoted, and then stored at −20°C. The solvent
was evaporated, and Ab was resuspended in 50 mM sodium hydrox-
ide. Synthetic Ab1–42/Ab1–40 HiLyte Fluor 488 (HF488) (AnaSpec,
San Jose, CA, USA) was dissolved in 1% ammonium hydroxide so-
lution (1 mg/ml), aliquoted, and then stored at −20°C. Labeled pep-
tides were used without further purification. Fluorescently labeled
amyloid fibrils were prepared by dissolving unlabeled Ab in buffer
[phosphate-buffered saline (PBS)] and adding HF488-labeled Ab
to give a final dye-to-protein ratio (i.e., labeled:unlabeled Ab) of
1:19, 1:99, and 1:499 at the 25 mM final protein concentration. The
solutions were sonicated and centrifuged for 10 min at 15,000g to
separate possible aggregates, and the pelleted fractions were dis-
carded. The supernatant was incubated at 25°C for 3 days without
agitation. AFM (fig. S5) and DLS were used to exclude the presence
of preaggregated peptides at the beginning of the fibrillation process.
Immunolabeling analysis
Labeling of the fibrils was done by standard immunofluorescence
staining. Ab1–42 was prepared as described above, and a drop of so-
lution after 4 days of aggregation in vitro was deposited on the mi-
croscope coverslip previously cleaned and treated with 1 M MgCl2.
The fibrils were then slightly rinsed and incubated overnight with
mousemonoclonal Ab1–42 antibody (Abcam, Cambridge, UK) (which
recognizesN-terminal residues 1 to 17 of humanAb) diluted in 1%bovine
serum albumin (BSA). The samples were rinsed three times with 1% BSA,
then incubatedwithAlexa Fluor 488 secondary antibody (Sigma-Aldrich,
St. Louis, MO, USA) diluted in 1% BSA for 2 hours, and rinsed again
with 1% BSA and PBS.Cosentino et al., Sci. Adv. 2019;5 : eaav8062 19 June 2019Light scattering
DLS measurements were performed with a Zetasizer Nano ZS sys-
tem (Malvern Instruments Ltd., Worcestershire, UK) at a protein
concentration of 0.05 mg/ml. Ab1–42 and Ab1–40 were dissolved in
water after pretreatment in 100% hexafluoroisopropanol and cen-
trifugation for seed removal. The measurements were done imme-
diately after centrifugation.
ThT assay
ThT solutions were purchased from Abcam (Cambridge, UK). The
stock solutions were prepared by dissolving 30 mg of dry powder in
1 ml of water. The solution was filtered through 0.22-mm syringe
filters and stored protected from light at 4°C for less than 2 weeks.
The ThT solution was diluted at different concentrations for each
protein. The final concentration of 100 mM with 50 mM insulin pro-
tein was used, while ThT at 50 mM with 25 mM Ab was used. A
twofold molar excess of ThT was used to ensure saturation of the
binding sites. The fluorescence was measured using a FluoroMax-4
spectrofluorometer (HORIBA Jobin Yvon Inc.) using an excitation
of 450 nm. The highest emission maximum observed was in the
insulin-bound ThT at 490 nm, while that in Ab-ThT at 488 nm.
AFM control measurements
AFM control measurements were performed with NanoWizard 3
(JPK Instruments, Berlin, Germany) mounted on an Axio Observer
D1 (Carl Zeiss, Oberkochen, Germany) inverted optical microscope.
Following a well-established methodology (13, 31, 35), a drop of the
sample solution (20 ml) was deposited on cutmuscovitemicamounted
on glass slides. The samples were adsorbed, rinsed with deionized wa-
ter to remove salts, and dried under a mild nitrogen flow before AFM
imaging. All imaging was performed in tapping mode both in air and
in liquid. Triangular silicon nitride cantilevers (DNP, Bruker, MA,
USA) with a tip, with a typical curvature radius of 20 to 60 nm, were
used for imaging in liquid. All images were acquired as 512 pixel–by–
512 pixel images with a scan rate between 0.6 and 1.0 Hz.
Correlative AFM/STED
ANanoWizard IIAFMhead (JPK, JPK Instruments, Berlin, Germany)
was mounted on a STED continuous wave gated microscope (Leica
TCS SP5 Gated STED CW, Leica Instrument). STED images were
collected with a Hybrid detector in a spectral range of 470 to 520 nm.
We used an HCX PL APO CS 100× 1.4 numerical aperture oil objec-
tive (Leica Microsystems, Mannheim, Germany) and a scan speed of
1000 Hz for 1024 pixels per line with a 32-line average and a time-
gated detection of 1.2 ns. The optical microscope stage was exchanged
with an AFM compatible stage (JPK Instruments, Berlin, Germany),
which features minimum mechanical coupling of noise to the AFM
cantilever. The direct overlay was available in the AFM software. A
short AFM scan helps fix a common point of origin between the two
image coordinates by shifting the STED image (36). Direct overlay
requires an image calibration file created for an objective and field of
view from an image sequence of AFM movements.
All the images of insulin samples were acquired in liquid (PBS, 1×)
working in tapping mode using triangular silicon nitride cantilevers
(DNP, Bruker, MA, USA) with a tip, with a typical curvature radius
of 20 to 60 nmand a nominal elastic constant of 0.24N/m. The images
on Ab samples were performed in air, using single-beam silicon can-
tilever probes (TESPA; Bruker, USA)with a typical radius of curvature
of 7 nm and a nominal spring constant of 37 N/m.6 of 7
SC I ENCE ADVANCES | R E S EARCH ART I C L EThe correlative images and the level of colocalization [Pearson’s
correlation coefficient (37, 38)] between AFMand optical images were
calculated using the colocalization function of ImageJ (Bethesda,
USA). An example is shown in fig. S7. In particular, the Colocalization
Threshold plugin was used. The threshold was automatically deter-
mined by the software using the Costes autothreshold method (39).
The scatter plots of the pixel by pixel correlation were also calculated
using the same ImageJ function and are shown in fig. S3.D
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/6/eaav8062/DC1
Fig. S1. AFM and ThT study of insulin aggregation process.
Fig. S2. Correlative images of insulin fibrils on a smaller area.
Fig. S3. Colocalization analysis between AFM and STED images.
Fig. S4. Confocal microscopy images.
Fig. S5. Ab after resuspension of the aggregation medium.
Fig. S6. Amyloid aggregates from Ab peptides.
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